Following this week’s announcement of a successful $10.5M capital raise, LTR Pharma’s Executive Chairman, Lee Rodne, spoke with ausbiz about future plans for the commercial launch of fast-acting nasal spray treatment for erectile dysfunction, SPONTAN.